Karen Joy Shaw

This inventor holds 10 USPTO granted patents and 6 published patent applications. Top assignees: Trius Therapeutics, Inc., Basilea Pharmaceutica International Ag, Allschwil, Janssen Pharmaceutica Nv. Active years: 1990-2026.

USPTO Granted Patents = 10 (Patent Applications = 6)

% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 43(Granted Patents)

Location History:

Oxford, NY (US) (1990)
Poway, CA (US) (2003 - 2013)

Company Filing History:

4 out of 8

Trius Therapeutics, Inc.

patents

2 out of 2

Basilea Pharmaceutica International Ag, Allschwil

patents

2 out of 2,100

Janssen Pharmaceutica Nv

patents

4. 2 out of 834,453

Other

patents

Years Active: 1990-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12521406 - Use of compounds in the treatment of fungal infections (2026-01-13),

2. 12139479 - Heterocycle substituted pyridine derivative antifungal agents (2024-11-12),

3. 8461188 - Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use (2013-06-11),

4. 8298543 - Identification and application of antibiotic synergy (2012-10-30),

5. 8242275 - Bicyclic pyrazole compounds as antibacterial agents (2012-08-14),

6. 8232391 - Bicyclic pyrazole compounds as antibacterial agents (2012-07-31),

7. 8021665 - Identification and application of antibiotic synergy (2011-09-20),

8. 7910337 - Method for identifying drug-sensitizing antisense DNA fragments and use thereof (2011-03-22),

9. 6505126 - Method to identify fungal genes useful as antifungal targets (2003-01-07),

10. 4944057 - Patient support and lifting device (1990-07-31),

Title: Karen Joy Shaw: Innovator in Antifungal and Antibiotic Research

Introduction

Karen Joy Shaw is a prominent inventor based in Poway, California. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of antifungal agents and antibiotic therapies. With a total of 10 patents to her name, her work has had a substantial impact on medical treatments.

Latest Patents

Among her latest patents, one notable invention is the "Heterocycle substituted pyridine derivative antifungal agents." This patent describes compounds that are effective in treating fungal diseases and infections. Another significant patent is the "Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use." This invention outlines a therapeutic combination that includes daptomycin and a protein synthesis inhibitor antibiotic, aimed at preventing the development of daptomycin non-susceptibility in bacteria.

Career Highlights

Throughout her career, Karen has worked with various organizations, including Trius Therapeutics, Inc. Her innovative research has led to advancements in the treatment of infections, showcasing her dedication to improving healthcare outcomes.

Collaborations

Karen has collaborated with notable professionals in her field, including Vickie L Brown-Driver and Kedar Gc. These partnerships have further enhanced her research and development efforts.

Conclusion

Karen Joy Shaw is a trailblazer in the pharmaceutical industry, with a focus on antifungal and antibiotic innovations. Her contributions continue to shape the landscape of medical treatments, making her a key figure in the field.